We are live on ! Find out more
BRM

Boston Research & Management Portfolio holdings

AUM $421M
1-Year Est. Return 16.18%
This Fund
S&P 500
This Quarter Est. Return
+4.93%
1 Year Est. Return
+16.18%
3 Year Est. Return
+48.21%
5 Year Est. Return
+65.09%
10 Year Est. Return
+242.1%
AUM
$184M
AUM Growth
+$7.78M
Cap. Flow
+$55K
Cap. Flow %
0.03%
Top 10 Hldgs %
22.89%
Holding
99
New
4
Increased
25
Reduced
35
Closed
3

Top Buys

Rank Stock Value
1
CL icon
Colgate-Palmolive
CL
+$534K
2
CVS icon
CVS Health
CVS
+$263K
3
IVV icon
iShares Core S&P 500 ETF
IVV
+$256K
4
MNDT
Mandiant, Inc. Common Stock
MNDT
+$225K
5
CLX icon
Clorox
CLX
+$207K

Top Sells

Rank Stock Value
1
AA icon
Alcoa
AA
+$695K
2
IYH icon
iShares US Healthcare ETF
IYH
+$396K
3
AAPL icon
Apple
AAPL
+$242K
4
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$201K
5
MSFT icon
Microsoft
MSFT
+$177K

Sector Composition

Rank Sector Weight
1 Industrials 17.31%
2 Technology 13.13%
3 Financials 12.23%
4 Healthcare 10.54%
5 Consumer Staples 10.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MOS icon
51
The Mosaic Company
MOS
$7.1B
$1.61M 0.88%
55,300
+1,220
+2% +$37.7K
HD icon
52
Home Depot
HD
$335B
$1.57M 0.85%
10,675
-30
-0.3% -$4.25K
VTI icon
53
Vanguard Total Stock Market ETF
VTI
$655B
$1.5M 0.82%
12,380
– –
JNJ icon
54
Johnson & Johnson
JNJ
$641B
$1.31M 0.71%
10,505
– –
CVX icon
55
Chevron
CVX
$378B
$1.15M 0.63%
10,702
+90
+0.8% +$10.1K
AMJ
56
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
$1.13M 0.61%
34,870
+750
+2% +$24.5K
GOOG icon
57
Alphabet (Google) Class C
GOOG
$3.99T
$1.05M 0.57%
25,440
-2,300
-8% -$94.3K
IAU icon
58
iShares Gold Trust
IAU
$63.4B
$915K 0.5%
38,115
+1,050
+3% +$24.7K
DIS icon
59
Walt Disney
DIS
$168B
$823K 0.45%
7,260
– –
CTAS icon
60
Cintas
CTAS
$84.4B
$800K 0.44%
25,316
– –
AOR icon
61
iShares Core 60/40 Balanced Allocation ETF
AOR
$3.64B
$790K 0.43%
18,642
+30
+0.2% +$1.25K
JPM icon
62
JPMorgan Chase
JPM
$947B
$764K 0.42%
8,701
-315
-3% -$27.8K
IBM icon
63
IBM
IBM
$204B
$752K 0.41%
4,517
– –
PFE icon
64
Pfizer
PFE
$141B
$717K 0.39%
22,104
– –
DUK icon
65
Duke Energy
DUK
$100B
$689K 0.38%
8,407
– –
BXP icon
66
Boston Properties
BXP
$11B
$642K 0.35%
4,850
– –
VEU icon
67
Vanguard FTSE All-World ex-US ETF
VEU
$65.9B
$632K 0.34%
13,219
– –
SYK icon
68
Stryker
SYK
$129B
$610K 0.33%
4,634
– –
AMLP icon
69
Alerian MLP ETF
AMLP
$12.7B
$565K 0.31%
8,903
-22
-0.2% -$1.41K
KMB icon
70
Kimberly-Clark
KMB
$37B
$496K 0.27%
3,775
– –
NEE icon
71
NextEra Energy
NEE
$185B
$467K 0.25%
14,560
– –
SYY icon
72
Sysco
SYY
$40.2B
$463K 0.25%
8,920
– –
MRK icon
73
Merck
MRK
$323B
$460K 0.25%
7,591
– –
PAYX icon
74
Paychex
PAYX
$41.1B
$456K 0.25%
7,755
– –
BMY icon
75
Bristol-Myers Squibb
BMY
$128B
$442K 0.24%
8,130
– –
1 2
3
4

Similar funds

SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
TFP
Triune Financial Partners Overland Park, Kansas $421M AUM 22.09% 1-Year Est. Return
CWM
Cordatus Wealth Management Newtown, Pennsylvania $420M AUM 24.63% 1-Year Est. Return
MG
MilWealth Group Milwaukee, Wisconsin $420M AUM 12.37% 1-Year Est. Return
HWMG
Hurlow Wealth Management Group Bloomington, Indiana $420M AUM 16.85% 1-Year Est. Return
AI
ArchPoint Investors Coral Gables, Florida $420M AUM 42.19% 1-Year Est. Return
LSWM
Lorne Steinberg Wealth Management Montreal, Quebec, Canada $422M AUM 23.86% 1-Year Est. Return
IMA
Investment Management Associates Greenwood Village, Colorado $420M AUM 11.81% 1-Year Est. Return

Boston Research & Management's Q1 2017 Portfolio in Review

As of Q1 2017, Boston Research & Management held 99 positions worth $184M, up 4.4% from $176M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Boston Research & Management's Q1 2017 filing shows 4 new, 25 increased, 35 reduced and 3 closed positions. Its largest new stake was Mandiant, Inc. Common Stock: 18,900 shares worth $238K. The largest sale was Alcoa, an estimated $695K.

By sector, the portfolio is most concentrated in Industrials at 17% of assets, down from 17% a quarter earlier, followed by Technology and Financials.

  • Boston Research & Management's largest Q1 2017 buy was Mandiant, Inc. Common Stock: 18,900 shares worth $238K.
  • Boston Research & Management added most to Colgate-Palmolive in Q1 2017, an estimated $534K increase.
  • Boston Research & Management's biggest Q1 2017 reduction was Apple, cutting an estimated $242K.
  • Boston Research & Management fully exited Alcoa in Q1 2017, selling an estimated $695K.
  • Boston Research & Management's ten largest holdings make up 23% of its $184M portfolio in Q1 2017.
  • Boston Research & Management opened 4 new positions and closed 3 in Q1 2017.
  • Boston Research & Management's portfolio value rose 4.4% quarter-over-quarter to $184M.

Based on Boston Research & Management's 13F filing for Q1 2017, filed 5 May 2017.